Nathan Rich
Stock Analyst at Goldman Sachs
(1.02)
# 3,724
Out of 4,945 analysts
84
Total ratings
35.48%
Success rate
-10.16%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $14.68 | +43.05% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $153.06 | +28.05% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $13.87 | +116.29% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $9.39 | -14.80% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $20.82 | -15.95% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $281.34 | +36.85% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $18.00 | -22.22% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $17.54 | -37.29% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $142.88 | +57.47% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $653.95 | -0.60% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $66.73 | +31.87% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $14.82 | -19.03% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $67.91 | +25.17% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $10.69 | +2.90% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $159.63 | +109.86% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $271.49 | +97.06% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $14.68
Upside: +43.05%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $153.06
Upside: +28.05%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $13.87
Upside: +116.29%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $9.39
Upside: -14.80%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $20.82
Upside: -15.95%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $281.34
Upside: +36.85%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $18.00
Upside: -22.22%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $17.54
Upside: -37.29%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $142.88
Upside: +57.47%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $653.95
Upside: -0.60%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $66.73
Upside: +31.87%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $14.82
Upside: -19.03%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $67.91
Upside: +25.17%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $10.69
Upside: +2.90%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $159.63
Upside: +109.86%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $271.49
Upside: +97.06%